Clinical Trials in Palermo, PA
32 recruiting
Showing 1–20 of 20 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263
Recruiting
Phase 3
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
Generalized Myasthenia Gravis
Novartis Pharmaceuticals146 enrolled112 locationsNCT06517758
Recruiting
Not Applicable
Urinary Gluten Immunogenic Peptides Detection in Non-celiac Gluten/Wheat Sensitivity
Non-celiac Gluten/Wheat Sensitivity
University of Palermo40 enrolled2 locationsNCT04219813
Recruiting
Phase 1Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Healthy Volunteers, Pulmonary Arterial Hypertension
Novartis Pharmaceuticals232 enrolled85 locationsNCT06649110
Recruiting
REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, PNH
Novartis Pharmaceuticals50 enrolled7 locationsNCT07229235
Recruiting
Phase 3
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Acute Myeloid LeukemiaRelapse/Recurrence
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS339 enrolled47 locationsNCT06713837
Recruiting
Phase 2
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals200 enrolled127 locationsNCT06470048
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS4,000 enrolled38 locationsNCT06459024
Recruiting
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals300 enrolled32 locationsNCT07093801
Recruiting
Not Applicable
Dietary Approach to Mild-to-moderate Psoriasis
PsoriasisGluten Sensitivity
University of Palermo82 enrolled3 locationsNCT05644782
Recruiting
Observational Study on Endometrial Stromal Tumors
Endometrial Stromal Tumors
Italian Sarcoma Group100 enrolled13 locationsNCT02829437
Recruiting
Study on Clinical Features and Outcomes of Breast Sarcoma
Breast Sarcoma
Italian Sarcoma Group300 enrolled14 locationsNCT04749446
Recruiting
An Observational Study on Epithelioid Sarcoma
Epithelioid Sarcoma
Italian Sarcoma Group100 enrolled11 locationsNCT03099681
Recruiting
Not Applicable
Wheat-free Diet in the Treatment of Sjogren's Syndrome
Sjogren's SyndromeNon-celiac Gluten Sensitivity
University of Palermo30 enrolled3 locationsNCT05644795
Recruiting
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,000 enrolled24 locationsNCT06806579
Recruiting
Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management
Hairy Cell Leukemia (HCL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna50 enrolled3 locationsNCT06774677
Recruiting
LOWER: Lomitapide Observational Worldwide Evaluation Registry
Homozygous Familial Hypercholesterolemia
Amryt Pharma300 enrolled75 locationsNCT02135705
Recruiting
BRING-UP 3 Heart Failure
Heart Failure
Heart Care Foundation10,000 enrolled187 locationsNCT06279988
Recruiting
BRING-UP Prevention
Peripheral Arterial DiseaseCerebrovascular DisordersIschemic Heart Disease
Heart Care Foundation6,000 enrolled196 locationsNCT06275113
Recruiting
Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease
AtherosclerosisCoronary Artery Disease
Azienda Ospedaliero-Universitaria di Parma1,000 enrolled11 locationsNCT01384721